Clinical controlled randomized trial of azathioprine in multiple sclerosis
A. Ghezzi(Azienda Ospedaliera Sant’Antonio Abate di Gallarate), C. L. Cazzullo(Associazione Italiana Sclerosi Multipla), Domenico Caputo(Don Carlo Gnocchi Foundation), S Marforio(Azienda Ospedaliera Sant’Antonio Abate di Gallarate), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Clara Locatelli(Azienda Ospedaliera Sant’Antonio Abate di Gallarate), Michela Falco(Azienda Ospedaliera Sant’Antonio Abate di Gallarate)
Unknown
January 1, 1989
Cited by 14
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Assessment of Normal-Appearing White and Gray Matter in Patients With Primary Progressive Multiple Sclerosis
|Archives of Neurology|2002|223